Congo's Ebola outbreak becomes second-deadliest on record as spread outpaces containment

The Democratic Republic of Congo is now home to the second-deadliest Ebola outbreak in recorded history. On a Sunday in mid-August, government data crossed a threshold that had been dreaded for months: confirmed deaths surpassed the toll from Congo's previous worst epidemic, the 2018-2020 outbreak that killed 2,299 people over two years. The current outbreak has already claimed 2,325 lives among 4,945 confirmed cases. Only the West African epidemic of 2014-2016, which killed more than 11,000 people across three countries, stands deadlier.

What makes this outbreak particularly alarming is not just its body count but its velocity. Health officials tracking the spread say it is moving five times faster than previous Ebola outbreaks in Congo at comparable stages. The 2018-2020 outbreak took more than ten months to reach 2,000 confirmed cases. This one reached that mark in roughly two months. The virus responsible is a rare species called Bundibugyo, and it had a head start that no one initially recognized. Early cases went undiagnosed, some mistaken for peritonitis. Local funeral practices, which involve close contact with the deceased, helped the virus move through communities before anyone sounded an alarm. When samples were finally sent to the capital for testing, they were mishandled. Worse, health workers were running tests designed for the wrong species of Ebola entirely. A peer-reviewed analysis published in Science concluded the outbreak had actually begun as early as January on the outskirts of Mongbwalu, a mining town in the east, but remained invisible until the official declaration in May.

The surveillance system designed to catch such outbreaks has been overwhelmed from the start. World Health Organization officials estimated in July that roughly 80 percent of new infections were emerging outside known transmission chains—meaning most people were identified as infected only after the virus had already spread through their communities. The surveillance teams themselves are stretched thin, understaffed, and in some cases unpaid. In June, Reuters reported that key parts of the response were facing severe funding and staffing shortfalls. USAID had been preparing to award a five-year contract for health surveillance in Congo when the agency was abruptly shuttered. By mid-July, the WHO had received less than half the funding it needed to fight the outbreak. Health workers protested over unpaid salaries, a reality that undermines morale and retention at a moment when every trained person matters.

The geographic and political context makes containment even harder. The outbreak is concentrated in eastern Congo, a region scarred by decades of armed conflict. Violence has blocked access to affected communities, disrupted the movement of personnel and supplies, and made contact tracing—the painstaking work of finding everyone an infected person encountered—nearly impossible. Hospitals and health teams have come under attack. Eastern Congo sits along major trade and migration routes, and people move constantly between towns, displacement camps, and neighboring countries, carrying the virus with them. In June, Reuters reported dozens of suspected Ebola deaths at a displacement camp, raising urgent questions about transmission among populations that are mobile, hard to monitor, and often beyond the reach of health systems.

The medical toolkit available to fight this outbreak is also severely limited. Unlike the Zaire species of Ebola behind the 2018-2020 outbreak, for which vaccines and treatments have been developed and proven effective, there is no licensed vaccine for Bundibugyo. There is no proven treatment either. Over the past decade, most vaccine development efforts focused on Zaire. A small number of experimental vaccines and therapies are now being evaluated, and global health authorities are assessing whether existing Ebola treatments might offer some protection, but the evidence so far comes only from animal studies. Health workers are fighting a virus they have limited tools to stop.

The rising case fatality rate tells part of the story of what this means on the ground. In early June, the rate stood around 20 percent. By mid-August, it had climbed to 47 percent. Experts caution that this does not mean the virus itself has become more lethal. Rather, it reflects the reality that many cases are still being detected late, after the disease has progressed further in the body. It is a measure of how far behind the response remains. The outbreak continues to accelerate, spreading faster than detection systems can identify it, faster than surveillance teams can trace it, and faster than the available medical interventions can contain it.